2015-06-16 21:08:43 UTC

Free Webinar on Managing Patients with HCV

June 16, 2015

Choose from three convenient dates in July to attend the webinar.

Hepatitis C (HCV) can be eradicated with treatment, but when left untreated the virus continues to make copies of itself inside the liver. Over time, this can cause cirrhosis, hepatocellular carcinoma and decompensated liver disease requiring liver transplantation. 

By participating in a new, free webinar The Challenging HCV Patient: Effective Processes to Improve Quality of Care and Outcomes, which is sponsored by PRIME though educational grants from Gilead, Inc. and Abbvie, Inc., you can learn how to manage challenging patients with HCV and these coexisting conditions.

Two expert faculty will discuss cases in HCV management and the various decision points in determining eligibility for treatment, liver fibrosis assessment, management of treatment-experienced patients, difficult-to-treat genotypes and HIV coinfection. The webinars are accredited for the interprofessional health-care team to promote improved collaboration and patient outcomes.

After viewing the webinar, attendees will be able to:

  • Differentiate HCV antiviral therapies based on current evidence for efficacy, safety, and appropriate patient and virus-specific treatment choices.
  • Apply evidence-based guidelines and best practices for promoting patient management strategies and optimizing outcomes.
  • Implement effective strategies for patient communication, education, engagement and shared decision-making about treatments for HCV infection.
  • Develop a plan of care for patients diagnosed with HCV and coexisting conditions.

Choose a convenient webinar date to attend:

  • Tuesday, July 14, 2015: 2 p.m. ET
  • Thursday, July 23, 2015: 2 p.m. ET
  • Wednesday, July 29, 2015: 2 p.m. ET

To register, visit www.primeinc.org.

More on Cirrhosis

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.

Spotlight on Fellow-Led Quality Improvement Projects

Oct. 3, 2017

These 19 projects presented at DDW® 2017 showcase the extensive work being done by fellows to improve the quality of care provided to GI patients.

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Oct. 1, 2017

Among HCV-infected patients treated with DAAs, SVR is associated with a considerable reduction in the risk of HCC; however, the risk for HCC remained high in patients with cirrhosis at the time of SVR.